Antipsychotics Market Forecast

Datamonitor
October 28, 2009
SKU: DFMN2500626
License type:
Countries covered: United States

Introduction

In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is the most rapid. However, the commercial opportunity still exists for developers who can differentiate their antipsychotics with reformulation and indication expansion strategies.

Reasons to Purchase
  • Quantify the performance of key marketed and pipeline antipsychotic drugs in the seven major markets over the period 2008 to 2018.
  • Dissect the split of the sales forecast by country, by molecule, by brand, and by indcation for key products.
  • Identify the leading brands in this drug class over the next 10 years and understand the key factors driving their success.
Please note: this is delivered as a Zip file.


More United States CNS/Neurology Reports

Mental Retardation Facilities in the US - Industry Risk Rating Report by IBISWorld
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Mental Retardation Facilities in the US industry. Industry Risk is assumed ...

Product Profiles: Autism Spectrum Disorders -Underserved market eagerly anticipates pipeline trial data by Datamonitor
Introduction Over the past 6 years, three major events have impacted the autism spectrum disorders market. In 2006, Risperdal became the first drug to ...

Case Study: Autism Spectrum Disorders - Public awareness and physician detailing will drive market growth by Datamonitor
Introduction To date, only two products have gained approval for the treatment of ASDs; Risperdal (risperidone; Johnson & Johnson) and Abilify (aripiprazole; Bristol-Myers Squibb/Otsuka Pharmaceuticals) are ...

2008 U.S. Drug Delivery: Neurological Disorders - Physician Perspective by Frost & Sullivan
This research service encompasses feedback on aspects of drug delivery and drug treatment provided by physicians in the U.S. who treat neurological disorders in order ...

Neurostimulation by Global Industry Analysts
This report analyzes the Global markets for Neurostimulation in US$ Million Tby the following Product Segments: Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>